Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications
暂无分享,去创建一个
Danielle Braun | Molly Griffin | Emanuele Mazzola | Molly Griffin | K. Hughes | A. Blackford | J. Plichta | J. Cintolo-Gonzalez | D. Braun | Emanuele Mazzola | A. Acar | Kevin S. Hughes | Amanda L. Blackford | Jessica A. Cintolo-Gonzalez | Ahmet Acar | Jennifer K. Plichta | E. Mazzola
[1] W. E. Hoogendoorn,et al. Modeling familial clustered breast cancer using published data. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[2] Adriano Decarli,et al. Risk factor modification and projections of absolute breast cancer risk. , 2011, Journal of the National Cancer Institute.
[3] L. Richardson,et al. Diagnostic Accuracy of the Gail Model in the Black Women’s Health Study , 2007, The breast journal.
[4] Barry I Graubard,et al. The risk of developing invasive breast cancer in Hispanic women , 2013, Cancer.
[5] N. Carson,et al. A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics center , 2000, Clinical genetics.
[6] A. LaCroix,et al. Evaluating breast cancer risk projections for Hispanic women , 2012, Breast Cancer Research and Treatment.
[7] M. Shoukier,et al. Validation of three BRCA1/2 mutation-carrier probability models Myriad, BRCAPRO and BOADICEA in a population-based series of 183 German families , 2011, Familial Cancer.
[8] J. Hopper,et al. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions , 2008, British Journal of Cancer.
[9] Z. Shao,et al. Evaluating the performance of models for predicting the BRCA germline mutations in Han Chinese familial breast cancer patients , 2009, Breast Cancer Research and Treatment.
[10] Ammarin Thakkinstian,et al. Risk prediction models of breast cancer: a systematic review of model performances , 2012, Breast Cancer Research and Treatment.
[11] Kee Seng Chia,et al. Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women , 2012, Breast Cancer Research.
[12] N E Day,et al. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes , 2002, British Journal of Cancer.
[13] D. Easton,et al. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families , 2005, Breast Cancer Research.
[14] D. Euhus. Understanding Mathematical Models for Breast Cancer Risk Assessment and Counseling , 2001, The breast journal.
[15] N. Obuchowski,et al. Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures , 2010, Epidemiology.
[16] N Risch,et al. Genetic analysis of breast cancer in the cancer and steroid hormone study. , 1991, American journal of human genetics.
[17] A. Lemke,et al. Evaluation of a breast/ovarian cancer genetics referral screening tool in a mammography population , 2009, Genetics in Medicine.
[18] D. West,et al. Accuracy of BRCA1/2 Mutation Prediction Models for Different Ethnicities and Genders: Experience in a Southern Chinese Cohort , 2012, World Journal of Surgery.
[19] J. Benichou,et al. Secular stability and reliability of measurements of the percentage of dense tissue on mammograms. , 2003, Cancer detection and prevention.
[20] K Offit,et al. BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. , 1997, JAMA.
[21] G. Colditz,et al. Validation of Rosner–Colditz breast cancer incidence model using an independent data set, the California Teachers Study , 2013, Breast Cancer Research and Treatment.
[22] Rongwei Fu,et al. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation , 2014, Annals of Internal Medicine.
[23] J. Oosterwijk,et al. Optimal selection for BRCA1 and BRCA2 mutation testing using a combination of ‘easy to apply’ probability models , 2006, British Journal of Cancer.
[24] Giovanni Parmigiani,et al. Simplifying clinical use of the genetic risk prediction model BRCAPRO , 2013, Breast Cancer Research and Treatment.
[25] Anthony Howell,et al. Breast cancer risk-assessment models , 2007, Breast Cancer Research.
[26] J. Wolfe,et al. Mammographic features and breast cancer risk: effects with time, age, and menopause status. , 1995, Journal of the National Cancer Institute.
[27] D. Easton,et al. BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface , 2013, British Journal of Cancer.
[28] N F Boyd,et al. Mammographic densities and breast cancer risk. , 1998, Breast disease.
[29] Peter Kraft,et al. Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] N. Rahman,et al. Update on the Manchester Scoring System for BRCA1 and BRCA2 testing , 2005, Journal of Medical Genetics.
[31] H. Nevanlinna,et al. A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families , 2001, British Journal of Cancer.
[32] M. Ennis,et al. Selecting a BRCA risk assessment model for use in a familial cancer clinic , 2008, BMC Medical Genetics.
[33] Julie O. Culver,et al. Limited family structure and BRCA gene mutation status in single cases of breast cancer. , 2007, JAMA.
[34] Melissa Bondy,et al. Projecting individualized absolute invasive breast cancer risk in African American women. , 2007, Journal of the National Cancer Institute.
[35] G A Colditz,et al. Nurses' health study: log-incidence mathematical model of breast cancer incidence. , 1996, Journal of the National Cancer Institute.
[36] F. Berrino,et al. Estimate of the penetrance of BRCA mutation and the COS software for the assessment of BRCA mutation probability , 2014, Familial Cancer.
[37] M. Morrow. Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial , 2007 .
[38] S. Narod. Re: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. , 1999, Journal of the National Cancer Institute.
[39] M. Rué,et al. An assessment of existing models for individualized breast cancer risk estimation in a screening program in Spain , 2013, BMC Cancer.
[40] F. Couch,et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. , 1997, The New England journal of medicine.
[41] W. McCaskill-Stevens,et al. Breast Cancer Risk Assessments Comparing Gail and CARE Models in African‐American Women , 2009, The breast journal.
[42] Karla Kerlikowske,et al. The contributions of breast density and common genetic variation to breast cancer risk. , 2015, Journal of the National Cancer Institute.
[43] M. Gail,et al. Is the Benign Breast Disease Breast Cancer Model Well Calibrated? , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[44] R. Eeles,et al. Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics , 2008, Journal of Medical Genetics.
[45] D. Amadori,et al. Intake of macronutrients and risk of breast cancer , 1996, The Lancet.
[46] Karla Kerlikowske,et al. Using Clinical Factors and Mammographic Breast Density to Estimate Breast Cancer Risk: Development and Validation of a New Predictive Model , 2008, Annals of Internal Medicine.
[47] A. Leitch,et al. Limitations of the Gail Model in the Specialized Breast Cancer Risk Assessment Clinic , 2002, The breast journal.
[48] D. Palli,et al. The Florence City Sample: Dietary and Life-Style Habits of a Representative Sample of Adult Residents. A Comparison with the Epic-Florence Volunteers , 2003, Tumori.
[49] Ivar Heuch,et al. Population attributable risk for breast cancer: diet, nutrition, and physical exercise. , 2000 .
[50] C. la Vecchia,et al. Population attributable risk for breast cancer: diet, nutrition, and physical exercise. , 1998, Journal of the National Cancer Institute.
[51] Jinbo Chen,et al. Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. , 2006, Journal of the National Cancer Institute.
[52] U. P. S. T. Force. Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Recommendation Statement , 2005, Annals of Internal Medicine.
[53] Karla Kerlikowske,et al. Benign breast disease, mammographic breast density, and the risk of breast cancer. , 2013, Journal of the National Cancer Institute.
[54] Susan M. Domchek,et al. Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of PENN II model to previous study , 2010, Familial Cancer.
[55] JoAnn E. Manson,et al. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. , 1998, Controlled clinical trials.
[56] D. Berry,et al. Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. , 1997, Journal of the National Cancer Institute.
[57] J. Cuzick,et al. Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[58] A Howell,et al. Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme , 2003, Journal of medical genetics.
[59] D. Easton,et al. The BOADICEA model of genetic susceptibility to breast and ovarian cancer , 2004, British Journal of Cancer.
[60] N. Risch,et al. The calculation of breast cancer risk for women with a first degree family history of ovarian cancer , 1993, Breast Cancer Research and Treatment.
[61] Mitchell H Gail,et al. Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women , 2017, Journal of the National Cancer Institute.
[62] S. Cummings,et al. Mammographic Breast Density and the Gail Model for Breast Cancer Risk Prediction in a Screening Population , 2005, Breast Cancer Research and Treatment.
[63] J. Kirk,et al. Evaluation of models to predict BRCA germline mutations , 2006, British Journal of Cancer.
[64] J. Lee,et al. Accuracy of BRCA1/2 mutation prediction models in Korean breast cancer patients , 2012, Breast Cancer Research and Treatment.
[65] V Shane Pankratz,et al. Model for individualized prediction of breast cancer risk after a benign breast biopsy. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[66] Stephen W Duffy,et al. A breast cancer prediction model incorporating familial and personal risk factors , 2004, Hereditary Cancer in Clinical Practice.
[67] Z. Miedzybrodzka,et al. Probability estimation models for prediction of BRCA1 and BRCA2 mutation carriers: COS compares favourably with other models , 2007, Familial Cancer.
[68] M. Yaffe,et al. American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007 .
[69] L. Ford,et al. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. , 2005, Journal of the National Cancer Institute.
[70] Karla Kerlikowske,et al. Prospective breast cancer risk prediction model for women undergoing screening mammography. , 2006, Journal of the National Cancer Institute.
[71] Konstantin Strauch,et al. Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance , 2012, Breast Cancer Research.
[72] C A Bodian,et al. Lobular neoplasia: Long term risk of breast cancer and relation to other factors , 1996, Cancer.
[73] U. P. S. T. Force,et al. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-related Cancer: US Preventive Services Task Force Recommendation Statement , 2019, Obstetrical & Gynecological Survey.
[74] M. Gail,et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.
[75] C. Specchia,et al. Epic-Italy Cohorts and Multipurpose National Surveys. A Comparison of Some Socio-Demographic and Life-Style Characteristics , 2003, Tumori.
[76] Jacques Simard,et al. Incorporating Truncating Variants in PALB2, CHEK2 and ATM into the BOADICEA Breast Cancer Risk Model , 2016, Genetics in Medicine.
[77] D Spiegelman,et al. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. , 2001, Journal of the National Cancer Institute.
[78] E. Halpern,et al. Mammographic breast density and race. , 2007, AJR. American journal of roentgenology.
[79] C K Redmond,et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.
[80] N. Rahman,et al. A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO , 2004, Journal of Medical Genetics.
[81] D. Berry,et al. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. , 1998, American journal of human genetics.
[82] M. Bani,et al. Evaluation of mathematical models for breast cancer risk assessment in routine clinical use , 2007, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[83] G. Colditz,et al. Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. , 2000, American journal of epidemiology.
[84] J Benichou,et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. , 1999, Journal of the National Cancer Institute.
[85] D. Noh,et al. Validation of Risk Assessment Models for Predicting the Incidence of Breast Cancer in Korean Women , 2014, Journal of breast cancer.
[86] V Shane Pankratz,et al. Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[87] Alan D. Lopez,et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study , 2017, JAMA oncology.
[88] Validity of Models for Predicting BRCA1 and BRCA2 Mutations , 2007, Annals of Internal Medicine.
[89] S. Cummings,et al. Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[90] E A Jones,et al. Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing , 2009, Journal of Medical Genetics.
[91] Spratt Js,et al. Assessing the risk of breast cancer. , 2000 .
[92] Susan M. Astley,et al. Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort , 2015, Breast Cancer Research.
[93] E. Schröck,et al. Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium , 2013, Journal of Medical Genetics.
[94] A. Meindl,et al. Validation of the Manchester scoring system for predicting BRCA1/2 mutations in 9,390 families suspected of having hereditary breast and ovarian cancer , 2014, International journal of cancer.
[95] Stephen W Duffy,et al. Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I , 2014, Breast Cancer Research.
[96] Sean V Tavtigian,et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[97] D Spiegelman,et al. Validation of the Gail et al. model for predicting individual breast cancer risk. , 1994, Journal of the National Cancer Institute.
[98] G. Mills,et al. Assessing BRCA carrier probabilities in extended families. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[99] Giovanni Parmigiani,et al. Recent Enhancements to the Genetic Risk Prediction Model BRCAPRO , 2015, Cancer informatics.
[100] D. Evans,et al. Assessing women at high risk of breast cancer: a review of risk assessment models. , 2010, Journal of the National Cancer Institute.
[101] D. Bowen,et al. Comparisons of two breast cancer risk estimates in women with a family history of breast cancer. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[102] D. English,et al. Associations of mammographic dense and nondense areas and body mass index with risk of breast cancer. , 2014, American journal of epidemiology.
[103] N Risch,et al. Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction , 1994, Cancer.
[104] Elpiniki I. Papageorgiou,et al. An integrated breast cancer risk assessment and management model based on fuzzy cognitive maps , 2015, Comput. Methods Programs Biomed..
[105] C. Jacobi,et al. Risk Estimation for Healthy Women from Breast Cancer Families , 2004, Cancer Epidemiology Biomarkers & Prevention.
[106] Alan B Hollingsworth,et al. An Alternative Approach to Selecting Patients for High‐risk Screening with Breast MRI , 2014, The breast journal.
[107] Thea D. Tlsty,et al. Benign breast disease and the risk of breast cancer. , 2005 .
[108] S. Singletary. Rating the Risk Factors for Breast Cancer , 2003, Annals of surgery.